The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs

Frontiers in Neurology - Switzerland
doi 10.3389/fneur.2020.00045
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Frontiers Media SA

Related search

SMN Blood Levels in a Porcine Model of Spinal Muscular Atrophy

Journal of Neuromuscular Diseases
Neurology
2017English

Muscle-Specific SMN Reduction Reveals Motor Neuron–independent Disease in Spinal Muscular Atrophy Models

Journal of Clinical Investigation
Medicine
2020English

ADrosophila Melanogastermodel of Spinal Muscular Atrophy Reveals a Function for SMN in Striated Muscle

Journal of Cell Biology
MedicineCell Biology
2007English

ML372 Blocks SMN Ubiquitination and Improves Spinal Muscular Atrophy Pathology in Mice

JCI insight
Medicine
2016English

Salbutamol Increases Survival Motor Neuron (SMN) Transcript Levels in Leucocytes of Spinal Muscular Atrophy (SMA) Patients: Relevance for Clinical Trial Design

Journal of Medical Genetics
Genetics
2010English

A Role for SMN Exon 7 Splicing in the Selective Vulnerability of Motor Neurons in Spinal Muscular Atrophy

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2011English

Gene Therapy in Mouse Models of Spinal Muscular Atrophy :||Using SMN Gene Replacement to Address Biological Questions

English

Current and Future Treatments of Spinal Muscular Atrophy

Developmental Medicine and Child Neurology
Child HealthDevelopmental NeurosciencePediatricsPerinatologyNeurology
2019English

Cost of Illness of Spinal Muscular Atrophy (SMA) in Italy

Global and Regional Health Technology Assessment
Health Policy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy